Press Releases | Medtronic

Month Year

Email alerts

Sep 28, 2016

Medtronic Receives FDA Approval for World's First Hybrid Closed Loop System for People with Type 1 Diabetes

The MiniMed® 670G System Features the Company's Most Advanced SmartGuard(TM) Algorithm To-Date

DUBLIN - Sept. 28, 2016 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) approval of its MiniMed® 670G...
Sep 27, 2016

Medtronic Announces First Live Experience of Sugar.IQ with Watson for People Living with Diabetes

Sugar.IQ with Watson Cognitive App to Preview at Health 2.0 Conference

DUBLIN and SANTA CLARA, Calif. - Sept. 27, 2016 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that Sugar.IQ with Watson, the first-of-its-kind cognitive app...
Sep 26, 2016

Medtronic's StealthStation® Cranial Software Receives FDA Clearance as an Aid for Deep Brain Stimulation Lead Placement

The Company Continues to Pioneer Innovations in Deep Brain Stimulation and Surgical Technologies by Launching the Only Fully-Integrated Procedural Solution for Neurosurgery

DUBLIN and SAN DIEGO - September 26, 2016 - Medtronic plc (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) clearance of StealthStation® Cranial Software as an aid for deep...
Sep 20, 2016

Medtronic Valiant Captivia Demonstrates Safety and Efficacy at Three Years

New Clinical Data Presented in Complicated Type B Aortic Dissection at VIVA 2016

DUBLIN and LAS VEGAS - Sept. 20, 2016 - Medtronic plc (NYSE: MDT) today announced new data, demonstrating safety and efficacy at three years in acute complicated Type B aortic dissection patients...
Sep 19, 2016

Analysis Shows Positive Association Between Cardiac Resynchronization Therapy and Patients' Increased Adherence to Heart Failure Medication Regimens

DUBLIN and ORLANDO, Fla. - Sept. 19, 2016 - Medtronic plc (NYSE:MDT) announced the results of an analysis that reveals patients increasingly adhere to heart failure medications after they receive...
Sep 19, 2016

New Data Presented in VIVA Late Breaking Clinical Trials Demonstrate Durability, Safety and Efficacy for the Medtronic In.Pact Admiral DCB

Multiple, Rigorous Analyses Reinforce the Excellent Outcomes of IN.PACT Admiral Drug Coated Balloon and Differentiate it as Best-in-Class Treatment Option for PAD

DUBLIN and LAS VEGAS - September 19, 2016 - Medtronic today reinforced the superior durability, consistency, and safety of the IN.PACT Admiral drug-coated balloon (DCB) in patients with peripheral...
Sep 15, 2016

Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services

Dublin - September 15, 2016 - Medtronic (NYSE: MDT) today announced the appointment of Mark Ploof as Senior Vice President, Global Operations and Business Services effective October 31, 2016. He...
Sep 15, 2016

The Journal of the American Medical Association Publishes Medtronic's Hybrid Closed Loop System Pivotal Trial Results

DUBLIN - September 15, 2016 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the publication of its Hybrid Closed Loop system pivotal trial results in the...
Sep 14, 2016

Medtronic Announces Approval and Launch of Reveal LINQ(TM) Insertable Cardiac Monitor in Japan

Miniaturized Device Now Available for Use in Patients with Unexplained Syncope and Stroke

DUBLIN - Sept. 14, 2016 - Medtronic plc (NYSE: MDT) today announced it has received Ministry of Health, Labor and Welfare (MHLW) approval of the Reveal LINQ Insertable Cardiac Monitor (ICM) System...
Sep 13, 2016

Medtronic Foundation Issues $250,000 in Health Access Grants to Support Local Diabetes Services in Northridge, California

Medtronic Foundation Grants Support Organizations Committed

NORTHRIDGE, Calif. - Sept. 13, 2016 - Medtronic Foundation today announced that five community organizations will receive a combined $250,000 in Health Access Grants in recognition of their...

Show per page